Fort Lauderdale, FL · Founded 2022 · Privately Held (backing)
Developer of epigenetic biomarkers intended to promote proactive pet healthcare. EpiPaws is based in Fort Lauderdale, FL and was founded in 2022. Its last reported valuation was $1.3 million in Dec 2024. It has raised $420,000.
Last reported valuation
$1.3M
Oct 2026
Priced at
—
Total raised
$420K
Last round
—
Team — not yet on record
No current team members for EpiPaws are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of EpiPaws with a free Private Market View account
·Watch EpiPaws: the Monday email on marks, rounds and moves
